OneSource
Ahmedabad, India· Est.
India’s first pure‑play specialty pharma CDMO delivering integrated oncology and drug‑delivery manufacturing solutions.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
India’s first pure‑play specialty pharma CDMO delivering integrated oncology and drug‑delivery manufacturing solutions.
OncologyDrug Delivery
Technology Platform
End‑to‑end specialty pharma CDMO with integrated capabilities across drug‑device combos, sterile injectables, biologics, and soft gelatin capsules, supported by GMP‑approved facilities and advanced process analytics.
Opportunities
Expanding demand for outsourced oncology biologics and advanced delivery devices in both emerging and mature markets offers significant revenue growth; leveraging digital analytics can further improve operational efficiency.
Risk Factors
Regulatory scrutiny in multiple jurisdictions and intense competition from established global CDMOs could pressure margins; reliance on a limited number of large pharma clients may affect revenue stability.
Competitive Landscape
Key competitors include Jubilant Biosys, Piramal Pharma, and Syngene; OneSource differentiates itself through its multimodal specialty focus and integrated tech‑transfer services.